Concomitant Surgical Ablation Using a Novel Bipolar Radiofrequency Clamp: Outcomes from the TRAC-AF Registry
<b>Background/Objectives</b>: Surgical ablation for atrial fibrillation (AF) during cardiac surgery decreases perioperative morbidity and mortality and improves long-term patient outcomes. Because of these benefits, it has been designated a Class I surgical society recommendation. As surgical ablation techniques have evolved, so too have ablation tools such as radiofrequency and cryothermal devices. In this study, we evaluated real-world evidence (RWE) of concomitant surgical ablation featuring an epicardial left atrial encircling lesion created by a novel bipolar radiofrequency clamp. <b>Methods</b>: Thirteen centers in the observational Tracking Results of Ablation to Combat AF (TRAC-AF) Registry (NCT05111015) contributed data used in this analysis. Included patients had AF and received the epicardial encircling lesion during cardiac surgery. Additional ablation and follow-up were per institutional standard of care. Freedom from AF/atrial tachycardia (AT)/atrial flutter (AFL) and survival were evaluated using the Kaplan-Meier method. Safety was evaluated within 30 days of the procedure. <b>Results</b>: Among 327 patients, 70% were male with a median age of 69 years. Sixty-nine percent had paroxysmal AF. Median left atrial diameter was 4.1 cm, and CHA<sub>2</sub>DS<sub>2</sub>-VASc score was 3. Isolated coronary artery bypass graft and aortic valve surgery were performed in 51% and 11% of patients, respectively. One- and two-year survival rates were 95.3% (95% CI, 91.7-97.3%) and 88.1% (95% CI, 81.5-92.5%). Through 12- and 24-months freedom from AF/AT/AFL was 87.4% (95% CI, 81.3-91.6%) and 79.9% (95% CI 72.0-85.8%). Mortality within 30 days of the index procedure was 1.5%. No serious adverse events were related to the epicardial cardiac ablation procedure or device. <b>Conclusions</b>: RWE from the TRAC-AF Registry demonstrates surgical ablation including an epicardial left atrial encircling lesion made by a novel bipolar RF clamp was safe and resulted in favorable long-term rhythm outcomes.
Authors
- Joshua Baugh (ORCID: https://orcid.org/0000-0001-7281-6306)
- Armin Kiankhooy (ORCID: https://orcid.org/0000-0001-7610-9406)
- Theodore Wright
- S. Holden
- Andrew Barksdale
- Eric L. Sievers (ORCID: https://orcid.org/0000-0002-0794-9441)
- Aaron Kime
- Gansevoort Dunnington
- Andres X. Samayoa (ORCID: https://orcid.org/0000-0002-7843-9457)
- Christian Shults
- Frans van Wagenberg
- Marc Gerdisch (ORCID: https://orcid.org/0000-0001-9489-038X)
- Gregory Rushing (ORCID: https://orcid.org/0000-0002-9685-9498)
- Hetal D. Patel (ORCID: https://orcid.org/0000-0001-9346-1591)
- Yasir Abu‐Omar (ORCID: https://orcid.org/0009-0005-0728-9884)
- Jeffrey Newman
- Andrew J. Sherman (ORCID: https://orcid.org/0009-0008-2287-1807)
Institutions
- Cedars-Sinai Medical Center (US)
- MedStar Washington Hospital Center (US)
- Huntsville Hospital (US)
- University Hospitals of Cleveland (US)
- Franciscan Health Indianapolis (US)
- Jackson-Madison County General Hospital (US)
- BayCare Health System (US)
- Tenet Healthcare (US)
- AtriCure (United States) (US)
- St. Helena Hospital (US)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3390/jcm14238360
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AtriCure